Management of Bleeding in Patients with Advanced Cancer

Management of Bleeding in Patients with Advanced Cancer Jose Pereira, Tien Phan Oncologist 2004; 9: 561-570 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in symptom management and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: List at least four local hemostatic agents and dressings for controlling localized bleeding in a patient with cancer. List at least four systemic therapies for controlling bleeding in a patient with advanced cancer. Describe a decision-making process related to managing bleeding in an end-of-life cancer patient. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Oct. 11, 2004 Most Recent Review: Oct. 11, 2004* Most Recent Update: Oct. 11, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.